APA (7th ed.) Citation

G, R., M, V., C, V., F, C., F, N., AD, V., & P, E. (2023). CYP2D6 genotyping and the clinical impact on outcomes in breast cancer tamoxifen-treated patients. Personalized medicine, 20(6), 477. https://doi.org/10.2217/pme-2023-0063

Chicago Style (17th ed.) Citation

G, Ramírez, Vital M, Vergara C, Carusso F, Neffa F, Valle AD, and Esperón P. "CYP2D6 Genotyping and the Clinical Impact on Outcomes in Breast Cancer Tamoxifen-treated Patients." Personalized Medicine 20, no. 6 (2023): 477. https://doi.org/10.2217/pme-2023-0063.

MLA (9th ed.) Citation

G, Ramírez, et al. "CYP2D6 Genotyping and the Clinical Impact on Outcomes in Breast Cancer Tamoxifen-treated Patients." Personalized Medicine, vol. 20, no. 6, 2023, p. 477, https://doi.org/10.2217/pme-2023-0063.